Knee OA gene therapy injection enters human trials
Disease control
Not yet recruiting
This early-stage study tests a single injection of ICM-203, a gene therapy designed to help regrow cartilage and reduce pain and inflammation in the knee. It involves 18 adults with mild to moderate knee osteoarthritis. The main goals are to check safety and see if the treatment …
Phase: PHASE1, PHASE2 • Sponsor: ICM Co. Ltd. • Aim: Disease control
Last updated May 17, 2026 06:48 UTC